Nanoscope Therapeutics Announces Participation at Eyecelerator® and ARVO 2025 Annual Meetings

Presentations to highlight efficacy, durability, and safety of Nanoscope's optogenetic therapy platforms DALLAS, April 25, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in blind patients in real-world settings by developing and...